Skip to content

Drug interactions

Erlotinib + Etrasimod

Severity: Major

Erlotinib and Etrasimod: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etrasimod lowers circulating lymphocytes, and erlotinib is an antineoplastic agent. Combined use may add to immune suppression and infection risk. The combination has not been studied.

What this interaction means in plain words

Erlotinib and Etrasimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Erlotinib belongs to Oncology; Etrasimod belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive pharmacodynamic immunosuppression through S1P receptor-mediated lymphocyte sequestration plus antineoplastic effects.

What to do

Avoid combining where an alternative exists. If unavoidable, monitor closely for infection and check blood counts, including lymphocytes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erlotinib and Etrasimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Erlotinib with Etrasimod?

MediHelp rates the interaction as major. Erlotinib and Etrasimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Etrasimod lowers circulating lymphocytes, and erlotinib is an antineoplastic agent. Combined use may add to immune suppression and infection risk. The combination has not been studied.

How serious is the interaction between Erlotinib and Etrasimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where an alternative exists. If unavoidable, monitor closely for infection and check blood counts, including lymphocytes.

What other medicines interact with Erlotinib?

MediHelp also lists interactions of Erlotinib with, for example, Amobarbital, Apalutamide, Carbamazepine. The full list is on the Erlotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in